Guillain-Barré Syndrome During the COVID-19 Pandemic and Pre-pandemic Periods

Background: Guillain-Barré Syndrome (GBS) is an autoimmune disease that may occur after infections. As Coronavirus Disease 2019 (COVID-19) bring about GBS, it important to assess the effect of COVID-19 pandemic on this Objectives: This study aimed compare distribution and characteristics GBS during before in academic referral hospital north Iran. Materials & Methods: retrospective assessed period (from March 2020 end February 2021) 2020) 5340 patients referred Neurology Ward Poursina Hospital Guilan Province, Results: There was no significant difference between (0.03%) (0.04%) (P=0.413). were also differences two periods regarding gender (P=0.659) age (P=0.417) patients. The most common subtype Acute Motor Sensory Axonal Neuropathy (AMSAN) (71.4%). In both periods, type treatment intravenous administration immune globulin. (P=0.838) patients’ response. Conclusion: its subtypes, treatment, response not different periods.